Congratulations to the team at Genprex as their company is now listed on the Russell 3000R index! This is an exciting step forward for the company’s health. We at Bear Creek Capital wish you all continued success with your scientific breakthroughs to help patients with cancer and diabetes.
“Genprex is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes.”
